PT96857A - Processo para a preparacao de oxetanonas - Google Patents

Processo para a preparacao de oxetanonas

Info

Publication number
PT96857A
PT96857A PT96857A PT9685791A PT96857A PT 96857 A PT96857 A PT 96857A PT 96857 A PT96857 A PT 96857A PT 9685791 A PT9685791 A PT 9685791A PT 96857 A PT96857 A PT 96857A
Authority
PT
Portugal
Prior art keywords
oxetanones
preparation
beta
novel
lactones
Prior art date
Application number
PT96857A
Other languages
English (en)
Other versions
PT96857B (pt
Inventor
Martin Karpf
Ulrich Zutter
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PT96857A publication Critical patent/PT96857A/pt
Publication of PT96857B publication Critical patent/PT96857B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C07D305/12—Beta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heat Treatment Of Steel (AREA)
  • Examining Or Testing Airtightness (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT96857A 1990-02-23 1991-02-22 Processo para a preparacao de oxetanonas PT96857B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH58990 1990-02-23
CH392590 1990-12-12

Publications (2)

Publication Number Publication Date
PT96857A true PT96857A (pt) 1991-10-31
PT96857B PT96857B (pt) 1998-07-31

Family

ID=25685045

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96857A PT96857B (pt) 1990-02-23 1991-02-22 Processo para a preparacao de oxetanonas

Country Status (18)

Country Link
US (2) US5245056A (pt)
EP (1) EP0443449B1 (pt)
JP (1) JP2912463B2 (pt)
KR (2) KR0183034B1 (pt)
AT (1) ATE153332T1 (pt)
AU (1) AU644846B2 (pt)
CA (1) CA2035972C (pt)
DE (1) DE59108707D1 (pt)
DK (1) DK0443449T3 (pt)
ES (1) ES2103751T3 (pt)
FI (1) FI115458B (pt)
GR (1) GR3024420T3 (pt)
HU (1) HU208686B (pt)
IE (1) IE910608A1 (pt)
NO (1) NO178764C (pt)
NZ (1) NZ237132A (pt)
PT (1) PT96857B (pt)
ZA (1) ZA911153B (pt)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5274143A (en) * 1991-07-23 1993-12-28 Hoffmann-La Roche Inc. Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione
AT398579B (de) * 1992-07-06 1994-12-27 Chemie Linz Gmbh Enzymatisches verfahren zur trennung racemischer gemische von delta-valerolactonen
DE4225817A1 (de) * 1992-08-05 1994-02-10 Chemie Linz Deutschland Enzymatisches Verfahren zur Trennung racemischer Gemische von delta-Valerolactonen
US5481008A (en) * 1993-09-13 1996-01-02 Hoffmann-La Roche Inc. Process for the preparation of optically active compounds
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
DE19703713A1 (de) * 1997-01-23 1998-07-30 Hans Prof Dr Schick Verfahren für die Herstellung von Oxetan-2-onen und Zwischenprodukte
RU2201272C2 (ru) * 1997-02-05 2003-03-27 Ф.Хоффманн-Ля Рош Аг Применение ингибиторов желудочно-кишечной липазы
AU9198698A (en) * 1997-09-15 1999-04-05 Warner-Lambert Company Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones
US7124221B1 (en) 1999-10-19 2006-10-17 Rambus Inc. Low latency multi-level communication interface
US6552204B1 (en) * 2000-02-04 2003-04-22 Roche Colorado Corporation Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
US6545165B1 (en) 2000-02-04 2003-04-08 Roche Colorado Corporation Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
EP1132389A1 (en) 2000-03-06 2001-09-12 Vernalis Research Limited New aza-indolyl derivatives for the treatment of obesity
EP1307263B1 (en) 2000-07-28 2005-04-20 F. Hoffmann-La Roche Ag New use of lipase inhibitors
CN1323661C (zh) 2000-08-09 2007-07-04 霍夫曼-拉罗奇有限公司 脂酶抑制剂的用途
US6900226B2 (en) 2000-09-06 2005-05-31 Hoffman-La Roche Inc. Neuropeptide Y antagonists
WO2002044152A1 (en) 2000-10-16 2002-06-06 F. Hoffmann-La Roche Ag Indoline derivatives and their use as 5-ht2 receptor ligands
GB0030710D0 (en) * 2000-12-15 2001-01-31 Hoffmann La Roche Piperazine derivatives
CN1250549C (zh) 2000-12-27 2006-04-12 霍夫曼-拉罗奇有限公司 吲哚衍生物及其作为5－ht2b和5－ht2c受体配体的应用
GB0106177D0 (en) 2001-03-13 2001-05-02 Hoffmann La Roche Piperazine derivatives
US20030027786A1 (en) 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
US6730319B2 (en) 2001-06-06 2004-05-04 Hoffmann-La Roche Inc. Pharmaceutical compositions having depressed melting points
US6787558B2 (en) 2001-09-28 2004-09-07 Hoffmann-La Roche Inc. Quinoline derivatives
US20050080255A1 (en) * 2001-12-13 2005-04-14 Yatendra Kumar Crystalline cefdinir potassium dihydrate
GB0202015D0 (en) * 2002-01-29 2002-03-13 Hoffmann La Roche Piperazine Derivatives
KR100659428B1 (ko) 2002-02-04 2006-12-19 에프. 호프만-라 로슈 아게 Ｎｐｙ 길항제로서의 퀴놀린 유도체
KR100611854B1 (ko) 2002-02-28 2006-08-11 에프. 호프만-라 로슈 아게 신경 펩타이드 ｙ(ｎｐｙ) 수용체 길항제로서의 티아졸유도체
US7728153B2 (en) 2002-04-17 2010-06-01 The Burnham Institute For Medical Research Method for the asymmetric synthesis of beta-lactone compounds
WO2003088975A1 (en) * 2002-04-17 2003-10-30 The Burnham Institute Inhibition of fatty acid synthase by beta-lactones and other compounds for inhibition of cellular proliferation
EP1560816A1 (en) 2002-07-05 2005-08-10 F. Hoffmann-La Roche Ag Quinazoline derivatives
US8861667B1 (en) 2002-07-12 2014-10-14 Rambus Inc. Clock data recovery circuit with equalizer clock calibration
EP1539722A1 (en) 2002-08-07 2005-06-15 F. Hoffmann-La Roche Ag Thiazole derivatives
EP1539746B1 (en) 2002-09-12 2006-11-15 F. Hoffmann-La Roche Ag N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes
US20040092735A1 (en) * 2002-11-08 2004-05-13 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of cefuroxime sodium
MXPA05005445A (es) 2002-11-25 2005-08-26 Hoffmann La Roche Derivados de indolilo.
GB0314967D0 (en) * 2003-06-26 2003-07-30 Hoffmann La Roche Piperazine derivatives
WO2005014592A1 (en) * 2003-08-12 2005-02-17 F. Hoffmann-La Roche Ag 2-amino-5-benzoylthiazole npy antagonists
WO2005014593A1 (en) * 2003-08-12 2005-02-17 F. Hoffmann-La Roche Ag Thiazole derivatives as npy antagonists
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
KR100895758B1 (ko) * 2005-05-03 2009-04-30 에프. 호프만-라 로슈 아게 5-ｈｔ2 리간드로서 테트라사이클릭 아자피라지노인돌린
JP2009504707A (ja) 2005-08-18 2009-02-05 エフ．ホフマン−ラ ロシュ アーゲー Ｈ３受容体調節剤として有用なチアゾリルピペリジン誘導体
EP1968967B1 (en) 2005-11-30 2011-04-27 F. Hoffmann-La Roche AG 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators
ATE466007T1 (de) 2005-11-30 2010-05-15 Hoffmann La Roche 5-substituierte indol-2-carbonsäureamidderivate
BRPI0619268A2 (pt) 2005-11-30 2011-09-20 Hoffmann La Roche compostos, processo para a sua manufatura, composições farmacêuticas, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de h3, uso dos compostos e método para o tratamento ou prevenção de obesidade e de diabetes do tipo ii em um ser humano ou animal
US7579351B2 (en) 2005-12-09 2009-08-25 Hoffmann-La Roche Inc. Tricyclic amide derivatives
ES2334580T3 (es) 2005-12-15 2010-03-12 F. Hoffmann-La Roche Ag Derivados de pirrolo(2,3-c)piridina.
AU2006326067A1 (en) 2005-12-16 2007-06-21 F. Hoffmann-La Roche Ag Pyrrolo [2 , 3-b] pyridine derivatives as H3 receptor modulators
BRPI0707916A2 (pt) * 2006-01-13 2011-05-17 Hoffmann La Roche compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem e uso destes compostos
ES2349160T3 (es) * 2006-01-23 2010-12-28 F. Hoffmann-La Roche Ag Derivados de la ciclohexil sulfonamida con actividad frente a los receptores h3.
US7432255B2 (en) 2006-05-16 2008-10-07 Hoffmann-La Roche Inc. 1H-indol-5-yl-piperazin-1-yl-methanone derivatives
AU2007267184A1 (en) 2006-05-30 2007-12-06 F. Hoffmann-La Roche Ag Piperidinyl pyrimidine derivatives
US7514433B2 (en) 2006-08-03 2009-04-07 Hoffmann-La Roche Inc. 1H-indole-6-yl-piperazin-1-yl-methanone derivatives
US20080146559A1 (en) 2006-12-08 2008-06-19 Li Chen 4,5,6,7-Tetrahydro-Thieno [2,3-C] Pyridine Derivatives
CN101348475B (zh) * 2007-07-20 2011-03-30 重庆人本药物研究院 一种奥利司他合成方法、中间体化合物及其制备方法
US7534788B2 (en) * 2007-07-25 2009-05-19 Hoffmann-La Roche Inc. Benzofuran and benzothiophene-2-carboxylic acid amide derivatives
KR101076680B1 (ko) * 2007-11-01 2011-10-26 한미홀딩스 주식회사 (6ｒ)-3-헥실-4-히드록시-6-운데실-5,6-다이히드로피란-2-온의 제조방법 및 이에 사용되는 중간체
KR101126084B1 (ko) * 2008-11-04 2012-03-29 한미홀딩스 주식회사 (3ｓ,4ｓ)-4-((ｒ)-2-(벤질옥시)트라이데실)-3-헥실-2-옥세타논의 제조방법 및 이에 사용되는 중간체
US9243040B2 (en) 2010-11-30 2016-01-26 The Board Of Trustees Of The University Of Illinois Stable helical ionic polypeptides
CN103588735A (zh) * 2013-11-13 2014-02-19 大连九信生物化工科技有限公司 一种奥利司他的结晶提纯方法
FR3017878B1 (fr) * 2014-02-27 2017-12-08 Charabot Procede de production de lactones a partir d'une souche d'aureobasidium pullulans
US11225507B2 (en) 2017-01-25 2022-01-18 The Board Of Trustees Of The University Of Illinois Conformation switchable antimicrobial peptides and methods of using the same
CN112625009A (zh) * 2020-12-18 2021-04-09 植恩生物技术股份有限公司 一种奥利司他关键中间体的精制方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3457193A (en) * 1965-06-30 1969-07-22 Union Carbide Corp Epoxyoxacyclobutanes and polymers thereof
DE2400429A1 (de) * 1974-01-05 1975-07-17 Basf Ag Verfahren zur herstellung von 4-ketotetrahydro-alpha-pyronen
US4395561A (en) * 1982-05-14 1983-07-26 The United States Of America As Represented By The Secretary Of The Navy Synthesis of 3-hydroxyoxetane
CA1270837A (en) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
CA1328881C (en) * 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
WO1988010258A1 (en) * 1987-06-17 1988-12-29 La Trobe University Human leucocyte elastase inhibitor compounds
HU202851B (en) * 1988-04-04 1991-04-29 Sandoz Ag Herbicidal or acaricidal compositions and process for producing the active ingredient aryldione derivatives
US5149835A (en) * 1989-04-27 1992-09-22 University Of New Mexico Substituted mevalonolactones, and methods for stereoselective preparation thereof and desmethyl homologues thereof
US5036008A (en) * 1989-07-12 1991-07-30 Bristol-Myers Company Antitumor antibiotic BU-3285T
US5110825A (en) * 1989-12-28 1992-05-05 Shionogi & Co., Ltd. Benzofuran derivative
IL97148A (en) * 1990-02-26 1996-11-14 Hoffmann La Roche Oxetanones a process for their manufacture and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
IE910608A1 (en) 1991-08-28
NO178764C (no) 1996-05-29
JPH04211675A (ja) 1992-08-03
FI910857A0 (fi) 1991-02-22
EP0443449A3 (en) 1991-12-04
HUT56558A (en) 1991-09-30
HU208686B (en) 1993-12-28
AU7116691A (en) 1991-08-29
KR100191365B1 (ko) 1999-06-15
NO910712D0 (no) 1991-02-22
NZ237132A (en) 1993-04-28
US5399720A (en) 1995-03-21
NO910712L (no) 1991-08-26
EP0443449B1 (de) 1997-05-21
GR3024420T3 (en) 1997-11-28
JP2912463B2 (ja) 1999-06-28
DE59108707D1 (de) 1997-06-26
ATE153332T1 (de) 1997-06-15
FI910857L (fi) 1991-08-24
CA2035972A1 (en) 1991-08-24
FI115458B (fi) 2005-05-13
KR0183034B1 (ko) 1999-05-01
US5245056A (en) 1993-09-14
EP0443449A2 (de) 1991-08-28
ES2103751T3 (es) 1997-10-01
DK0443449T3 (da) 1997-11-24
AU644846B2 (en) 1993-12-23
KR910021393A (ko) 1991-12-20
CA2035972C (en) 2006-07-11
ZA911153B (en) 1991-11-27
PT96857B (pt) 1998-07-31
NO178764B (no) 1996-02-19

Similar Documents

Publication Publication Date Title
PT96857A (pt) Processo para a preparacao de oxetanonas
DK0582790T3 (da) Ny fremgangsmåde til fremstilling af 7-substituerede-9-[(substitueret glycyl)-amino]-6-demethyl-6-deoxytetracycliner
PT874853E (pt) Processo de preparacao de cefdinir
PT97796A (pt) Processo para a preparacao de piperidinas substituidas
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
BR9206823A (pt) Preparação de piperidinas substituídas
BR9509373A (pt) Processo para a preparação de 3- aminobenzonitrilas substituídas
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
FI875596A0 (fi) Foerfarande foer framstaellning av tienyletylaminer och aeven ditienyletylaminer.
BR9400016A (pt) Processo para preparação de compostos, e compostos
AU4787696A (en) Production of enantiomerically enriched ortho-substituted alpha,alpha-diaromatic methanols
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
BR9806875A (pt) Processo para a preparação de um composto.
DE69513408D1 (de) Ein verbessertes verfahren für die herstellung von seitenketten-derivaten von cyclohexapeptidyl-lipopeptiden
BR9909151A (pt) processos para preparação de intermediários
BR9808047B1 (pt) processo para a preparação de 2-nitroguanidinas 1,3-dissubstituìdas.
ES2140683T3 (es) Procedimiento para preparar compuestos de benzopirano.
BR9910370A (pt) Compostos de cefalosporina, processo para preparar compostos de cefalosporina, e, composições antimicrobianas
PT99378A (pt) Processo para a preparacao de intermediarios uteis para a preparacao de acido 4,5-difluoroantranilico
PT1056769E (pt) 15-metil-ciclopropanoesteroides e processo para a sua preparacao
IT1270834B (it) Disolfuro chinolico
BR9201895A (pt) Processo para preparar 2-(aminometil)-4-tiazolmetanol e compostos
RU94030731A (ru) Асимметрично замещенные производные диаминодикарбоновой кислоты и способ их получения
AR005042A1 (es) Procedimiento para la preparacion de un antagonista endotelin.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910704

FG3A Patent granted, date of granting

Effective date: 19980408

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20130408